GGrantIndex
← Leaderboards

Joseph Paul Taylor

St. Jude Children'S Research Hospital

$16,109,089
Attributed
$16,109,089
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,109,089 · 7

By mechanism

R35$8,050,325 · 2
R01$5,186,771 · 2
U54$2,254,993 · 2
K22$617,000 · 1

Top collaborators

No co-investigators on record.

Most similar at St. Jude Children'S Research Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsMolecularMutationBaseGeneticMotor NeuronsGenesPathogenesisNeurodegenerative DisordersInsightTherapeutic InterventionPathway InteractionsNuclearPolyglutamineNerve DegenerationToxic EffectImpairmentDrosophila GenusReceptor GeneSpinobulbar Muscular AtrophyAndrogen ReceptorDefectProgramsAmyotrophic Lateral Sclerosis

Grant awards (35)

Dynamic RNA-Protein Assemblies and Neurological Disease$897,250
R35 · FY2025 · NS · contact PI
Dynamic RNA-protein assemblies and neurological disease$870,575
R35 · FY2024 · NS · contact PI
Dynamic RNA-protein assemblies and neurological disease$897,500
R35 · FY2023 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #2$419,519
U54 · FY2023 · NS · contact PI
Dynamic RNA-protein assemblies and neurological disease$897,500
R35 · FY2022 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #2$506,220
U54 · FY2022 · NS · contact PI
Dynamic RNA-protein assemblies and neurological disease$897,500
R35 · FY2021 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #2$412,831
U54 · FY2021 · NS · contact PI
Dynamic RNA-protein assemblies and neurological disease$897,500
R35 · FY2020 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #2$448,885
U54 · FY2020 · NS · contact PI
Dynamic RNA-protein assemblies and neurological disease$897,500
R35 · FY2019 · NS · contact PI
Clinical Research in ALS & Related Disorders for Therapeutic Development (CReATe) - Project Core #2$467,538
U54 · FY2019 · NS · contact PI
Dynamic RNA-protein assemblies and neurological disease$897,500
R35 · FY2018 · NS · contact PI
Dynamic RNA-protein assemblies and neurological disease$897,500
R35 · FY2017 · NS · contact PI
Pathways of Neurodegeneration in SBMA$382,813
R01 · FY2015 · NS · contact PI
Pathways of Neurodegeneration in SBMA$378,985
R01 · FY2014 · NS · contact PI
Pathways of Neurodegeneration in SBMA$369,415
R01 · FY2013 · NS · contact PI
Pathways of Neurodegeneration in SBMA$382,813
R01 · FY2012 · NS · contact PI
HDAC6 and the intersection between the UPS, autophagy, and neurodegeneration$320,283
R01 · FY2012 · AG · contact PI
Pathways of Neurodegeneration in SBMA$382,813
R01 · FY2011 · NS · contact PI
HDAC6 and the intersection between the UPS, autophagy, and neurodegeneration$320,437
R01 · FY2011 · AG · contact PI
HDAC6 and the intersection between the UPS, autophagy, and neurodegeneration$333,529
R01 · FY2010 · AG · contact PI
Pathways of neurodegeneration in SBMA$321,732
R01 · FY2010 · NS · contact PI
HDAC6 and the intersection between the UPS, autophagy, and neurodegeneration$337,050
R01 · FY2009 · AG · contact PI
Pathways of neurodegeneration in SBMA$182,826
R01 · FY2009 · NS · contact PI
Pathways of neurodegeneration in SBMA$142,156
R01 · FY2009 · NS · contact PI
HDAC6 and the intersection between the UPS, autophagy, and neurodegeneration$354,200
R01 · FY2008 · AG · contact PI
Pathways of neurodegeneration in SBMA$318,765
R01 · FY2008 · NS · contact PI
Pathways of neurodegeneration in SBMA$319,004
R01 · FY2007 · NS · contact PI
Molecular pathogenesis of polyglutamine disease$81,000
K22 · FY2007 · NS · contact PI
Pathways of neurodegeneration in SBMA$339,950
R01 · FY2006 · NS · contact PI
Molecular pathogenesis of polyglutamine disease$162,000
K22 · FY2006 · NS · contact PI
Molecular pathogenesis of polyglutamine disease$162,000
K22 · FY2005 · NS
Molecular pathogenesis of polyglutamine disease$162,000
K22 · FY2004 · NS
Molecular pathogenesis of polyglutamine disease$50,000
K22 · FY2004 · NS